<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02951884</url>
  </required_header>
  <id_info>
    <org_study_id>208755</org_study_id>
    <nct_id>NCT02951884</nct_id>
  </id_info>
  <brief_title>Effect of Local Anesthetic Injection and Hemarthrosis Aspiration on Pain and Narcotic/Opioid Analgesia Use-Tibial Plateau Fractures</brief_title>
  <official_title>Effect of Local Anesthetic Injection and Hemarthrosis Aspiration on Pain and Narcotic/Opioid Analgesia Use-Tibial Plateau Fractures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loyola University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loyola University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate pain level experienced by patients who have a break of the top of
      their shinbone and have either blood removed from the joint alone or have blood removed and
      medicine injected into the joint.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be randomly assigned to one of three groups.

      Group 1 will receive aspiration of the joint alone in which a needle will be introduced into
      the knee joint to withdraw the blood that collects within the knee after fractures.

      Group 2 will receive aspiration of the knee joint (the same as Group 1) and will receive an
      injection of 20cc bupivacaine 0.5% with 1:200,000 epinephrine, which is a local anesthetic
      commonly used for the numbing of skin.

      Group 3 will receive no injection or aspiration therapy; instead will be treated as normally
      treated for this type of fracture.

      After the aspiration or the aspiration and injection:

      Initial pain score will be recorded immediately. Subsequent pain scores will be recorded at
      time points 0 (5 minutes after intervention), 2, 4, 6, 8, 12, 24 hours after initial work-up.
      If patient treated as an outpatient then patent will be asked to self-record pain scores on a
      scale of 0-10 (0= no pain and 10= worst pain you have ever had). In all cases patients will
      be managed appropriately for the injury.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2, 2017</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numerical Rating Scale (NRS) pain scores</measure>
    <time_frame>Immediately - at time of patient initial work-up</time_frame>
    <description>NRS score recorded immediately with Subsequent Visual Analog Scale (VAS) at time points identified in following outcomes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analog Scale (VAS)</measure>
    <time_frame>5 minutes after intervention</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analog Scale (VAS)</measure>
    <time_frame>2 hours after intervention</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analog Scale (VAS)</measure>
    <time_frame>4 hours after intervention</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analog Scale (VAS)</measure>
    <time_frame>6 hours after intervention</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analog Scale (VAS)</measure>
    <time_frame>8 hours after intervention</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analog Scale (VAS)</measure>
    <time_frame>12 hours after intervention</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analog Scale (VAS)</measure>
    <time_frame>24 hours after intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Use of supplemental analgesia (pain medicine)</measure>
    <time_frame>During the 24 hour period post intervention</time_frame>
    <description>Administration of supplemental analgesia will be recorded and converted to morphine equivalent units for analysis.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Tibial Fractures</condition>
  <condition>Pain</condition>
  <condition>Analgesia</condition>
  <condition>Aspiration</condition>
  <arm_group>
    <arm_group_label>Aspiration Knee Joint</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Withdrawal of Blood Collected within Knee Joint</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aspiration and Injection Knee Joint</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Withdrawal of Blood Collected within Knee Joint Injection of 20cc bupivacaine 0.5% with 1:200,000 epinephrine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard Care</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Aspiration Knee Joint</intervention_name>
    <description>Aspiration Knee Joint - a needle is placed into the knee joint and all of the blood that is in the joint is taken out.</description>
    <arm_group_label>Aspiration Knee Joint</arm_group_label>
    <arm_group_label>Aspiration and Injection Knee Joint</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine with Epinephrine</intervention_name>
    <description>Injection of 20 cc bupivacaine 0.5% with 1:200,00 epinephrine</description>
    <arm_group_label>Aspiration and Injection Knee Joint</arm_group_label>
    <other_name>Marcaine</other_name>
    <other_name>Exparel</other_name>
    <other_name>Sensorcaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with isolated tibial plateau fractures aged 18 years and older

          -  Patients with tibial plateau fractures and associated soft tissue complaints about the
             knee, not associated with a fracture outside of the tibial plateau

          -  Patients with bilateral tibial plateau fractures and no other noted fractures

        Exclusion Criteria:

          -  Any Patient that does not wish to participate in the study or is unable to give
             consent at the initial encounter will be excluded.

          -  Patients under 18 years old

          -  Pregnant patients

          -  Patients with mental disabilities who are unable to give consent

          -  Incarcerated patients

          -  Inability or unwillingness to consent for participation

          -  History of allergic reaction to local anesthetics

          -  Emergent conditions requiring operations or airway protection

          -  Polytrauma patients

          -  Patients presenting for care &gt; 24 hours following their injury.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>William Lack, MD</last_name>
    <phone>708-216-1175</phone>
    <email>wlack@lumc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tammy Rhoda, MPH</last_name>
    <phone>708-216-5494</phone>
    <email>trhoda@luc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Lack, MD</last_name>
      <phone>708-216-1175</phone>
      <email>wlack@lumc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Tammy Rhoda, MPH</last_name>
      <phone>708-216-5494</phone>
      <email>trhoda@luc.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Manidakis N, Dosani A, Dimitriou R, Stengel D, Matthews S, Giannoudis P. Tibial plateau fractures: functional outcome and incidence of osteoarthritis in 125 cases. Int Orthop. 2010 Apr;34(4):565-70. doi: 10.1007/s00264-009-0790-5. Epub 2009 May 14.</citation>
    <PMID>19440710</PMID>
  </reference>
  <reference>
    <citation>Koval KJ, Helfet DL. Tibial Plateau Fractures: Evaluation and Treatment. J Am Acad Orthop Surg. 1995 Mar;3(2):86-94.</citation>
    <PMID>10790657</PMID>
  </reference>
  <reference>
    <citation>Stein C, Comisel K, Haimerl E, Yassouridis A, Lehrberger K, Herz A, Peter K. Analgesic effect of intraarticular morphine after arthroscopic knee surgery. N Engl J Med. 1991 Oct 17;325(16):1123-6.</citation>
    <PMID>1653901</PMID>
  </reference>
  <reference>
    <citation>Busch CA, Shore BJ, Bhandari R, Ganapathy S, MacDonald SJ, Bourne RB, Rorabeck CH, McCalden RW. Efficacy of periarticular multimodal drug injection in total knee arthroplasty. A randomized trial. J Bone Joint Surg Am. 2006 May;88(5):959-63.</citation>
    <PMID>16651569</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 28, 2016</study_first_submitted>
  <study_first_submitted_qc>October 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2016</study_first_posted>
  <last_update_submitted>December 7, 2017</last_update_submitted>
  <last_update_submitted_qc>December 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Loyola University</investigator_affiliation>
    <investigator_full_name>William Lack</investigator_full_name>
    <investigator_title>Assistant Professor/Orthopaedic Surgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Tibial Fractures</mesh_term>
    <mesh_term>Hemarthrosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
    <mesh_term>Narcotics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

